The National Aeronautics and Space Administration (NASA) recently announced the creation of a Planetary Defense Coordination Office (PDCO) to help detect and track thousands of asteroids passing near Earth each year.
The central office will manage all NASA-funded projects to detect, monitor and characterize asteroids and comets that pass near Earth's orbit. If an actual impact threat is detected, the office will also coordinate NASA's response with the Federal Emergency Management Agency (FEMA) and other US federal agencies.
"While there are no known impact threats at this time, the 2013 Chelyabinsk super-fireball and the recent 'Halloween Asteroid' close approach remind us of why we need to remain vigilant and keep our eyes to the sky," John Grunsfeld, associate administrator for NASA's Science Mission Directorate in Washington, said in a statement.
NASA says there have been more than 13,500 Near Earth Objects [NEOs] of varying sizes discovered since NASA-funded surveys began in 1998. According to current NASA data, roughly 1,500 NEOs are detected each year. The new office will focus on finding mid-sized but still potentially hazardous objects that are 450 feet (137 meters) or larger.
The organization's long-term planetary defense goals will focus on developing technologies and techniques for deflecting or redirecting objects that pose a threat of impacting Earth. Such techniques include NASA's Asteroid Redirect Mission, which plans to launch a spacecraft to an asteroid where it will capture a boulder for later analysis and redirect the asteroid to a stable orbit around the moon. The joint NASA-European Space Agency Asteroid Impact and Deflection Assessment (AIDA) mission scheduled for 2022 will test the ability to redirect an asteroid by hitting it with a spacecraft.
If the new office finds that there is no way to intervene with an asteroid impacting Earth, NASA would provide expert advice and data to FEMA and other government agencies so that they can prepare for an emergency response.


Trump Signs Executive Order to Boost AI Research in Childhood Cancer
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Neuralink Expands Brain Implant Trials with 12 Global Patients
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tabletop particle accelerator could transform medicine and materials science
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 



